GAVI Fully Approves $1 Billion African Vaccine Manufacturing Accelerator to Make Continent Self-Sufficient
By Tony Malesi
After a long-drawn process and debate on vaccine sovereignty and continental health security, the Global Vaccine Alliance (GAVI) board has fully approved the final structure of the African Vaccine Manufacturing Accelerator (AVMA).
AVMA, which will be launched on June 20, 2024, is a financing mechanism aimed at creating a sustainable vaccine manufacturing industry in Africa. GAVI’s board had partially approved a few of AVMA’s operations last year and had been hammering out the remaining details around the total operationalisation of the financial instrument.
Photo courtesy of Focal Foto.
Source: Down To Earth (link opens in a new window)
- Categories
- Health Care
